Arrowhead Research | ARWR - Interest Income


Arrowhead Research reported $9.69M in Interest Income for its fiscal quarter ending in December of 2025.





Interest Income Change Date
Agios Pharmaceuticals USD 12.41M 959K Dec/2025
Alnylam Pharmaceuticals USD 26.63M 2.05M Dec/2025
Arrowhead Research USD 9.69M 637K Dec/2025
Heron Therapeutics USD 433K 277K Dec/2021
Incyte USD 33.69M 2.93M Mar/2026
Ionis Pharmaceuticals USD -0.66 0.29 Dec/2024
Ligand Pharmaceuticals USD 6.39M 2.52M Dec/2025
Merck USD 69M 27M Dec/2025
Moderna USD 70M 3M Dec/2025
Nektar Therapeutics USD -0.18 0.07 Sep/2024
Sarepta Therapeutics USD 8.74M 359K Dec/2025
Ultragenyx Pharmaceutical USD 6.51M 649K Dec/2025
Vertex Pharmaceuticals USD 114.8M 7.1M Mar/2026
Xencor USD 6.2M 338K Dec/2025